[
  {
    "date": "2023-12-30",
    "symbol": "SRPT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "SRPT",
    "entityregistrantname": "Sarepta Therapeutics, Inc.",
    "entitycentralindexkey": 873303,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityfilenumber": "001-14895",
    "entitytaxidentificationnumber": "93-0797222",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "215 First Street",
    "entityaddressaddressline2": "Suite 415",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 617,
    "localphonenumber": "274-4000",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.0001 par value",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "auditorname": "KPMG LLP",
    "auditorlocation": "Boston, MA",
    "auditorfirmid": 185,
    "cashandcashequivalentsatcarryingvalue": 428430000,
    "shortterminvestments": 1247820000,
    "accountsreceivablenetcurrent": 400327000,
    "inventorynet": 322859000,
    "otherassetscurrent": 179895000,
    "assetscurrent": 2579331000,
    "propertyplantandequipmentnet": 227154000,
    "operatingleaserightofuseasset": 129952000,
    "inventorynoncurrent": 191368000,
    "otherassetsnoncurrent": 136771000,
    "assets": 3264576000,
    "accountspayablecurrent": 164918000,
    "accruedliabilitiescurrent": 314997000,
    "contractwithcustomerliabilitycurrent": 50416000,
    "longtermdebtcurrent": 105483000,
    "operatingleaseliabilitycurrent": 17845000,
    "liabilitiescurrent": 653659000,
    "longtermloanspayable": 1132515000,
    "operatingleaseliabilitynoncurrent": 140965000,
    "contractwithcustomerliabilitynoncurrent": 437000000,
    "businesscombinationcontingentconsiderationliability": 38100000,
    "otherliabilitiesnoncurrent": 3000000,
    "liabilities": 2405239000,
    "commonstockvalue": 9000,
    "additionalpaidincapitalcommonstock": 5304623000,
    "accumulatedothercomprehensiveincomelossnetoftax": 918000,
    "retainedearningsaccumulateddeficit": -4446213000,
    "stockholdersequity": 859337000,
    "liabilitiesandstockholdersequity": 3264576000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 3333333,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 198000000,
    "commonstocksharesissued": 93731831,
    "commonstocksharesoutstanding": 93731831,
    "revenuefromcontractwithcustomerexcludingassessedtax": 1144876000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2023#ProductMember",
    "revenuefromcollaborativearrangementexcludingrevenuefromcontractwithcustomer": 98460000,
    "revenues": 1243336000,
    "costofgoodssoldexcludingamortization": 150343000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 877387000,
    "sellinggeneralandadministrativeexpense": 481871000,
    "amortizationofintangibleassets": 1559000,
    "costsandexpenses": 1511160000,
    "operatingincomeloss": -267824000,
    "gainslossesonextinguishmentofdebt": -387329000,
    "gainlossondispositionofintangibleassets": 102000000,
    "othernonoperatingincomeexpense": 33055000,
    "nonoperatingincomeexpense": -252274000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -520098000,
    "incometaxexpensebenefit": 15879000,
    "netincomeloss": -535977000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 2582000,
    "othercomprehensiveincomelossnetoftax": 2582000,
    "comprehensiveincomenetoftax": -533395000,
    "earningspersharebasic": -5.8,
    "earningspersharediluted": -5.8,
    "weightedaveragenumberofsharesoutstandingbasic": 92398000,
    "weightedaveragenumberofdilutedsharesoutstanding": 92398000,
    "sharesoutstanding": 93732,
    "stockissuedduringperiodvaluestockoptionsexercised": 40485000,
    "stockissuedduringperiodsharesstockoptionsexercised": 528,
    "restrictedstockunitsvested": 645,
    "issuanceofcommonstockforexchangeofnotesshares": 4456,
    "issuanceofcommonstockforexchangeofnotesvalue": 693377000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 10761000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 153,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrestrictedstockunitsrequisiteserviceperiodrecognition": 182514000,
    "partialsettlementofcappedcallshareoptionsfor2024notes": 80645000,
    "othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletononcontrollinginterest": -2582000,
    "profitloss": -535977000,
    "depreciationdepletionandamortization": 44397000,
    "reductioninthecarryingamountsoftherightofuseassets": 14495000,
    "noncashinterestexpense": 5156000,
    "sharebasedcompensation": 182514000,
    "accretionofinvestmentdiscountnet": -46176000,
    "equitymethodinvestmentotherthantemporaryimpairment": 30321000,
    "othernoncashincomeexpense": -37000,
    "increasedecreaseinaccountsreceivable": 185699000,
    "increasedecreaseininventories": 147714000,
    "increasedecreaseinotheroperatingassets": 10713000,
    "increasedecreaseindeferredrevenue": -86828000,
    "increasedecreaseinaccountspayableandaccruedexpensesandotherliabilities": -50135000,
    "netcashprovidedbyusedinoperatingactivities": -500993000,
    "proceedsfromsaleofintangibleassets": 102000000,
    "paymentstoacquirepropertyplantandequipment": 76106000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 2044940000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 1868482000,
    "paymentstoacquireintangibleassets": 11239000,
    "acquisitionofstrategicinvestments": -4000000,
    "netcashprovidedbyusedininvestingactivities": -165803000,
    "proceedsfromstockoptionsexercised": 51246000,
    "debtconversioncosts": 6887000,
    "netcashprovidedbyusedinfinancingactivities": 125004000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -541792000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 444009000,
    "restrictedcashnoncurrent": 15579000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 444009000,
    "interestpaidnet": 15923000,
    "incometaxespaidnet": 15081000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 80203000,
    "noncashorpartnoncashacquisitionfixedassetsacquired1": 33339000,
    "cashcashequivalentsandshortterminvestments": 1691800000,
    "numberofoperatingsegments": 1,
    "accountsreceivablepaymentterm": "P60D",
    "taxbenefitpercentage": 0.5,
    "finitelivedintangibleassetusefullife": "P20Y",
    "commonstockclosingpricepercentage": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.15,
    "advertisingexpense": 28600000,
    "operatingleaseliability": 18500000,
    "concentrationriskpercentage1": 0.4,
    "thresholdturnoveramount": 20000000000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet",
    "paymentforoptionexercise": 165800000,
    "collaborationreceivablecurrent": 9200000,
    "contractwithcustomerliability": 487400000,
    "deferredrevenuecurrent": 50400000,
    "deferredrevenueseparatematerialoptionsright": 485000000,
    "researchanddevelopmentexpense": 106900000,
    "collaborationreceivable": 29800000,
    "upfrontanddevelopmentmilestoneexpenses": 7500000,
    "finitelivedintangibleassetsnet": 29620000,
    "royaltyexpense": 17600000,
    "intangibleassetsnetexcludinggoodwill": 23000000,
    "developmentmilestoneandsettlementupfrontfeerecognizedasresearchanddevelopmentexpense": 3200000,
    "milestonepaymenttobepaidbycompanyuponspecifiedresearchmilestoneachievement": 34800000,
    "inventorycost": 1800000,
    "proceedsfromsaleofrarepediatricdiseasepriorityreviewvoucher": 102000000,
    "assetsfairvaluedisclosure": 63919000,
    "liabilitiesfairvaluedisclosure": 38100000,
    "strategicequityinvestmentmemberaddition": 4000000,
    "transfersoutoflevels3": -4000000,
    "assetsfairvalueadjustment": -30000000,
    "liabilitiesterminated": -800000,
    "liabilitiesfairvalueadjustment": 2000000,
    "strategicinvestmentsnoncurrent": 5500000,
    "cashequivalentsatcarryingvalue": 63919000,
    "weightedaveragematurityperiodofavailableforsalesecurities": "P5M",
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 1006000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 171000,
    "availableforsalesecuritiesdebtsecurities": 113362000,
    "cashandcashequivalentsamortizedcostbasis": 374750000,
    "cashcashequivalentsandinvestmentsamortizedcostbasis": 428430000,
    "cashcashequivalentsandinvestmentsgrossunrealizedgainbeforetax": 1124000,
    "cashcashequivalentsandinvestmentsgrossunrealizedlossbeforetax": 179000,
    "cashcashequivalentsandinvestments": 1676250000,
    "availableforsaledebtsecuritiescurrentamortizedcostbasis": 1246875000,
    "availableforsaledebtsecuritiescurrentaccumulatedgrossunrealizedgainbeforetax": 1124000,
    "availableforsaledebtsecuritiescurrentaccumulatedgrossunrealizedlossbeforetax": 179000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 1247820000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 428430000,
    "billedcontractreceivables": 400300000,
    "valuationallowancesandreservesbalance": 27486000,
    "provisionforreservesfordiscountsandallowances": 44191000,
    "adjustmentstoproductrevenuereservesrelatingtosalesinprioryears": 536000,
    "paymentscreditsreservesfordiscountsandallowances": 17658000,
    "reservesforreductiontoaccountsreceivable": 64697000,
    "reservesforcomponentofaccruedexpenses": 100075000,
    "allowancefordoubtfulaccountsreceivablecurrent": 164772000,
    "inventoryrawmaterialsnetofreserves": 133963000,
    "inventoryworkinprocess": 318458000,
    "inventoryfinishedgoodsnetofreserves": 61806000,
    "inventorycurrentandnoncurrentnet": 514227000,
    "manufacturingrelateddepositsandprepaidexpensecurrent": 102181000,
    "collaborationandotherreceivablecurrent": 29786000,
    "prepaidmaintenanceservicescurrent": 11281000,
    "prepaidclinicalandpreclinicalexpensescurrent": 10280000,
    "valueaddedtaxreceivable": 6862000,
    "prepaidinsurance": 3352000,
    "interestreceivablecurrent": 2731000,
    "prepaidexpensecurrentandnoncurrent": 2729000,
    "prepaidresearchexpensescurrent": 2512000,
    "otherassetsmiscellaneouscurrent": 8181000,
    "manufacturingrelateddepositsandprepaidexpensenoncurrent": 74204000,
    "prepaidmaintenanceservicesnoncurrent": 5466000,
    "prepaidexpensenoncurrent": 2133000,
    "otherassetsmiscellaneousnoncurrent": 3242000,
    "propertyplantandequipmentgross": 108101000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 190970000,
    "depreciation": 42500000,
    "finitelivedintangibleassetsgross": 32673000,
    "finitelivedintangibleassetsaccumulatedamortization": 8244000,
    "finitelivedintangibleassetsremainingamortizationperiod1": "P13Y9M18D",
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 2717000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 2660000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 2528000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 2458000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 2377000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 16880000,
    "finitelivedintangibleassetsamortizationexpenseonethroughfiveyears": 29620000,
    "accruedproductrevenuerelatedreservecurrent": 100075000,
    "employeerelatedliabilitiescurrent": 78732000,
    "accruedclinicalandpreclinicalcostscurrent": 34669000,
    "accruedcontractmanufacturingexpensecurrent": 33024000,
    "accruedprofessionalfeescurrent": 17187000,
    "accruedincometaxes": 13766000,
    "accruedroyaltiescurrent": 12070000,
    "accruedmilestoneexpensecurrent": 11375000,
    "interestpayablecurrent": 4395000,
    "accruedcollaborationcostsharing": 1076000,
    "otheraccruedliabilitiescurrent": 8628000,
    "debtinstrumentfaceamount": 105800000,
    "conversionofsharesexcludedfromcomputationofdilutedeps": 1400000,
    "deferredfinancecostsnet": 364000,
    "otherlongtermdebtcurrent": 105500,
    "interestexpensedebt": 22000000,
    "amortizationoffinancingcosts": 5200000,
    "longtermdebt": 1237998000,
    "debtinstrumentfairvalue": 144833000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 105847000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 14375000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 14375000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 1150000000,
    "commonstockcapitalsharesreservedforfutureissuance": 300000,
    "commonstockincreaseincapitalsharesreservedforfutureissuanceinperiodshares": 7000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1186399,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 48500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 70.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 502225,
    "employeebenefitsandsharebasedcompensation": 26300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "550,110 options relating to the Unvested Tranche became vested as they met the conditions for vesting as a result of the average closing price of the Company's common stock exceeding $128.65 and $105.74 during 20 consecutive trading days and the compound annual growth rate of the Company's common stock exceeding that of the Nasdaq Biotech Index by greater than 5%",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 550110,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 70.91,
    "compoundannualgrowthrate": 0.05,
    "allocatedsharebasedcompensationexpense": 13400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationincrementalcompensationcost": 123300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "2024-02-29",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 82600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 260700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.035,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.049,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y2M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.468,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.632,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9582695,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 204935,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5951953,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 9216033,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 78.57,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 147.71,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 76.68,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 103.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 77.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 288119000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 202405000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 285706000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P5Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P4Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P5Y6M",
    "aggregategrantdatefairvalueofsharesvested": 142692000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 29711000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 2240504,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1165925,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 644614,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 110439,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 120.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 151.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 93.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 112.27,
    "saleofstockconsiderationreceivedontransaction": 10800000,
    "definedcontributionplancostrecognized": 8800000,
    "interestexpense": 22010000,
    "investmentincomeinterest": 36257000,
    "amortizationofdiscountspremiumsinvestmentscashequivalentandshortterminvestment": 49712000,
    "gainlossoncontingentconsiderationsnet": -1200000,
    "othernonrecurringincomeexpense": 617000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -238660000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -281438000,
    "currentfederaltaxexpensebenefit": 4180000,
    "currentstateandlocaltaxexpensebenefit": 11111000,
    "currentforeigntaxexpensebenefit": 753000,
    "currentincometaxexpensebenefit": 16044000,
    "deferredforeignincometaxexpensebenefit": -165000,
    "deferredincometaxexpensebenefit": -165000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.077,
    "effectiveincometaxratereconciliationresearchanddevelopmentandothertaxcredit": 0.283,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.137,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.002,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.02,
    "effectiveincometaxratereconciliationdeductionexcessbenefitstockdeductions": 0.016,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.113,
    "effectiveincometaxratereconciliationnondeductiblepremiumonnoteconversion": -0.153,
    "effectiveincometaxratereconciliationotheradjustments": -0.038,
    "effectiveincometaxratecontinuingoperations": -0.031,
    "nondeductiblepremiumpaidontheconversion1": 379900000,
    "currentfederalstateandlocaltaxexpensebenefit": 4200000,
    "valuationallowancedeferredtaxassetchangeinamount": 71800000,
    "operatinglosscarryforwards": 550300000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 262200000,
    "operatinglosscarryforwardsexpirationyear": 2024,
    "deferredtaxassetsoperatinglosscarryforwards": 154948000,
    "taxcreditcarryforwarddescription": "These federal and state research and development credits expire between 2024 and 2043 and between 2024 and 2038, respectively.",
    "taxcreditcarryforwardamount": 102600000,
    "federalorphandrugtaxcredits": 239400000,
    "deferredtaxassetsdepreciationandamortization": 36611000,
    "deferredtaxassetsinprocessresearchanddevelopment": 374017000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 94452000,
    "deferredtaxassetsleaseliabilities": 33792000,
    "deferredtaxassetsinventory": 35269000,
    "deferredtaxassetsdebtdiscount": 25597000,
    "capitalizedresearchanddevelopmentcosts": 106534000,
    "deferredtaxassetsother": 50308000,
    "deferredtaxassetsgross": 911528000,
    "deferredtaxliabilitiesrightofuseasset": 25800000,
    "deferredincometaxliabilities": 25800000,
    "deferredtaxassetsvaluationallowance": 883665000,
    "deferredtaxassetsliabilitiesnet": 2063000,
    "unrecognizedtaxbenefits": 65030000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 4126000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 800000,
    "lesseeoperatingleasetermofcontract": "P15Y",
    "paymentsforrent": 38900000,
    "paymentsforproceedsfromtenantallowance": 13100000,
    "reductiontorightofuseassetsandleaseliabilities": 72000000,
    "operatingleasecost": 29895000,
    "variableleasecost": 38442000,
    "leasecost": 68337000,
    "operatingleasepayments": 21608000,
    "operatingleaseweightedaverageremainingleaseterm1": "P11Y2M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.091,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 33718000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 34477000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 28006000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 27995000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 28611000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 245835000,
    "lesseeoperatingleaseliabilitypaymentsdue": 398642000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 239832000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityCurrent",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 12000000,
    "agreementexpirationdate": "2026-12-31",
    "agreementextensionterm": "The Company has the option to extend the term of the Aldevron Agreements by one year if the Company delivers a written notice of its intention to extend to Aldevron no later than June 1, 2025. Both parties have the right to early terminate without additional penalty. The Company has determined that the Aldevron Agreements do not contain an embedded lease because it does not convey the right to control the use of Aldevron’s facility or related equipment therein.",
    "cancellablefuturecommitments": 580000000,
    "researchanddevelopmentarrangementcontracttoperformforotherscostsincurredgross": 112200000,
    "nonrefundableadvancepayments": 2600000,
    "contractualobligationdueinnexttwelvemonths": 1032159000,
    "contractualobligationdueinsecondyear": 150767000,
    "contractualobligationdueinthirdyear": 106984000,
    "contractualobligationdueinfourthyear": 77640000,
    "contractualobligationdueinfifthyear": 72280000,
    "contractualobligation": 1439830000
  },
  {
    "date": "2022-12-30",
    "symbol": "SRPT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "SRPT",
    "entityregistrantname": "Sarepta Therapeutics, Inc.",
    "entitycentralindexkey": 873303,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityfilenumber": "001-14895",
    "entitytaxidentificationnumber": "93-0797222",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "215 First Street",
    "entityaddressaddressline2": "Suite 415",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 617,
    "localphonenumber": "274-4000",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.0001 par value",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "KPMG LLP",
    "auditorlocation": "Boston, Massachusetts",
    "auditorfirmid": 185,
    "cashandcashequivalentsatcarryingvalue": 966777000,
    "shortterminvestments": 1022597000,
    "accountsreceivablenetcurrent": 214628000,
    "inventorynet": 203968000,
    "otherassetscurrent": 149891000,
    "assetscurrent": 2557861000,
    "propertyplantandequipmentnet": 180037000,
    "finitelivedintangibleassetsnet": 7578000,
    "operatingleaserightofuseasset": 64954000,
    "otherassetsnoncurrent": 317936000,
    "assets": 3128366000,
    "accountspayablecurrent": 95875000,
    "accruedliabilitiescurrent": 418996000,
    "contractwithcustomerliabilitycurrent": 89244000,
    "otherliabilitiescurrent": 15489000,
    "liabilitiescurrent": 619604000,
    "longtermloanspayable": 1544292000,
    "operatingleaseliabilitynoncurrent": 57578000,
    "contractwithcustomerliabilitynoncurrent": 485000000,
    "businesscombinationcontingentconsiderationliability": 36900000,
    "otherliabilitiesnoncurrent": 42000,
    "liabilities": 2743416000,
    "commonstockvalue": 9000,
    "additionalpaidincapitalcommonstock": 4296841000,
    "accumulatedothercomprehensiveincomelossnetoftax": -1664000,
    "retainedearningsaccumulateddeficit": -3910236000,
    "stockholdersequity": 384950000,
    "liabilitiesandstockholdersequity": 3128366000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 3333333,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 198000000,
    "commonstocksharesissued": 87950117,
    "commonstocksharesoutstanding": 87950117,
    "revenuefromcontractwithcustomerexcludingassessedtax": 843769000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2022#ProductMember",
    "revenuefromcollaborativearrangementexcludingrevenuefromcontractwithcustomer": 89244000,
    "revenues": 933013000,
    "costofgoodssoldexcludingamortization": 139989000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 877090000,
    "sellinggeneralandadministrativeexpense": 451421000,
    "amortizationofintangibleassets": 714000,
    "costsandexpenses": 1469214000,
    "operatingincomeloss": -536201000,
    "gainslossesonextinguishmentofdebt": -125441000,
    "gainlossoncontingentconsiderationsnet": 6700000,
    "othernonoperatingexpense": 35021000,
    "nonoperatingincomeexpense": -153762000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -689963000,
    "incometaxexpensebenefit": 13525000,
    "netincomeloss": -703488000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -1644000,
    "othercomprehensiveincomelossnetoftax": -1644000,
    "comprehensiveincomenetoftax": -705132000,
    "earningspersharebasic": -8.03,
    "earningspersharediluted": -8.03,
    "weightedaveragenumberofsharesoutstandingbasic": 87559000,
    "weightedaveragenumberofdilutedsharesoutstanding": 87559000,
    "sharesoutstanding": 87950000,
    "stockissuedduringperiodvaluestockoptionsexercised": 22573000,
    "stockissuedduringperiodsharesstockoptionsexercised": 318000,
    "restrictedstockunitsvested": 389000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 7470000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 116000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrestrictedstockunitsrequisiteserviceperiodrecognition": 233018000,
    "purchaseofcappedcallshareoptionsfor2027notes": 127305000,
    "partialsettlementofcappedcallshareoptionsfor2024notes": 26317000,
    "othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletononcontrollinginterest": 1644000,
    "profitloss": -703488000,
    "depreciationdepletionandamortization": 41864000,
    "reductioninthecarryingamountsoftherightofuseassets": 12735000,
    "noncashinterestexpense": 7552000,
    "sharebasedcompensation": 233018000,
    "gainlossonsaleofotherassets": -10770000,
    "equitymethodinvestmentotherthantemporaryimpairment": 2575000,
    "othernoncashincomeexpense": 9643000,
    "increasedecreaseinaccountsreceivable": 61638000,
    "increasedecreaseininventories": 50780000,
    "increasedecreaseinotheroperatingassets": -14620000,
    "increasedecreaseindeferredrevenue": -89244000,
    "increasedecreaseinaccountspayableandaccruedexpensesandotherliabilities": 147572000,
    "netcashprovidedbyusedinoperatingactivities": -325346000,
    "paymentstoacquirepropertyplantandequipment": 30824000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 1936856000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 923224000,
    "otherinvestingactivity": 2427000,
    "netcashprovidedbyusedininvestingactivities": -1046883000,
    "proceedsfromnotespayable": 1127400000,
    "paymentsofdebtissuancecosts": 716000,
    "repurchaseofdebt": -247868000,
    "repaymentsoflongtermdebtandcapitalsecurities": 550000000,
    "paymentsofdebtextinguishmentcosts": 25364000,
    "proceedsfromstockoptionsexercised": 30043000,
    "netcashprovidedbyusedinfinancingactivities": 232507000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -1139722000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 985801000,
    "restrictedcashnoncurrent": 19024000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 985801000,
    "interestpaidnet": 44418000,
    "incometaxespaidnet": 1695000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 40006000,
    "leaseliabilitiesterminated": 3807000,
    "noncashorpartnoncashacquisitionfixedassetsacquired1": 6765000,
    "cashcashequivalentsandshortterminvestments": 2008400000,
    "restrictedcashandinvestmentsnoncurrent": 19000000,
    "numberofoperatingsegments": 1,
    "accountsreceivablepaymentterm": "P60D",
    "taxbenefitpercentage": 0.5,
    "finitelivedintangibleassetusefullife": "P20Y",
    "commonstockclosingpricepercentage": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.15,
    "operatingleaseliability": 16400000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "Lesser of the useful life or the term of   the respective lease",
    "paymentforoptionexercise": 243800000,
    "contractwithcustomerliability": 574200000,
    "deferredrevenuecurrent": 89200000,
    "deferredrevenueseparatematerialoptionsright": 485000000,
    "researchanddevelopmentexpense": 117800000,
    "collaborationreceivable": 41800000,
    "upfrontanddevelopmentmilestoneexpenses": 8500000,
    "researchanddevelopmentexpensescharges": 17100000,
    "royaltyexpense": 30400000,
    "intangibleassetsnetexcludinggoodwill": 1000000,
    "developmentmilestoneandsettlementupfrontfeerecognizedasresearchanddevelopmentexpense": 32600000,
    "milestonepaymenttobepaidbycompanyuponspecifiedresearchmilestoneachievement": 41800000,
    "obligationsduetodevelopmentregulatorycommercialmilestoneandupfrontroyaltypayments": 3200000000,
    "assetsfairvaluedisclosure": 467553000,
    "liabilitiesfairvaluedisclosure": 36900000,
    "strategicequityinvestmentmemberaddition": 1163000,
    "assetsfairvalueadjustment": -2575000,
    "liabilitiesfairvalueadjustment": -6700000,
    "cashequivalentsatcarryingvalue": 467553000,
    "weightedaveragematurityperiodofavailableforsalesecurities": "P4M",
    "availableforsalesecuritiesdebtsecuritiescurrent": 1022597000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 178000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1542000,
    "availableforsalesecuritiesdebtsecurities": 211369000,
    "cashandcashequivalentsamortizedcostbasis": 801979000,
    "cashandcashequivalentsgrossunrealizedgainbeforetax": 9000,
    "cashcashequivalentsandinvestmentsamortizedcostbasis": 966768000,
    "cashcashequivalentsandinvestmentsgrossunrealizedgainbeforetax": 187000,
    "cashcashequivalentsandinvestmentsgrossunrealizedlossbeforetax": 1824000,
    "cashcashequivalentsandinvestments": 1989374000,
    "availableforsaledebtsecuritiescurrentamortizedcostbasis": 1024243000,
    "availableforsaledebtsecuritiescurrentaccumulatedgrossunrealizedgainbeforetax": 178000,
    "availableforsaledebtsecuritiescurrentaccumulatedgrossunrealizedlossbeforetax": 1824000,
    "billedcontractreceivables": 214600000,
    "concentrationriskpercentage1": 0.48,
    "allowancefordoubtfulaccountsreceivablecurrent": 417000,
    "provisionforreservesfordiscountsandallowances": 12446000,
    "paymentscreditsreservesfordiscountsandallowances": -12828000,
    "reservesforreductiontoaccountsreceivable": 25914000,
    "reservesforcomponentofaccruedexpenses": 68784000,
    "inventoryrawmaterialsnetofreserves": 59181000,
    "inventoryworkinprocessandrawmaterialsnetofreserves": 269185000,
    "inventoryfinishedgoodsnetofreserves": 38147000,
    "inventorycurrentandnoncurrentnet": 366513000,
    "inventorynoncurrent": 162545000,
    "manufacturingrelateddepositsandprepaidexpensecurrent": 66455000,
    "collaborationreceivablecurrent": 41758000,
    "prepaidclinicalandpreclinicalexpensescurrent": 11237000,
    "prepaidmaintenanceservicescurrent": 9815000,
    "prepaidinsurance": 3717000,
    "interestreceivablecurrent": 3311000,
    "prepaidexpensecurrentandnoncurrent": 2947000,
    "prepaidresearchexpensescurrent": 1927000,
    "prepaidtaxes": 1002000,
    "otherassetsmiscellaneouscurrent": 7722000,
    "otherinventorynoncurrent": 162545000,
    "manufacturingrelateddepositsandprepaidexpensenoncurrent": 97409000,
    "strategicinvestmentsnoncurrent": 31321000,
    "prepaidexpensenoncurrent": 2150000,
    "otherassetsmiscellaneousnoncurrent": 5487000,
    "propertyplantandequipmentgross": 97328000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 148876000,
    "depreciation": 40000000,
    "finitelivedintangibleassetsgross": 8573000,
    "finitelivedintangibleassetsaccumulatedamortization": 6403000,
    "inlincensedrights": 1000000,
    "expensesincurredoncapitalizedpatentstobeabandoned": 6000000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1032000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1026000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 969000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 837000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 767000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 2947000,
    "finitelivedintangibleassetsamortizationexpenseonethroughfiveyears": 7578000,
    "accruedcontractmanufacturingexpensecurrent": 202173000,
    "accruedproductrevenuerelatedreservecurrent": 68784000,
    "employeerelatedliabilitiescurrent": 65946000,
    "accruedclinicalandpreclinicalcostscurrent": 28884000,
    "accruedincometaxes": 12521000,
    "accruedprofessionalfeescurrent": 12061000,
    "accruedroyaltiescurrent": 8636000,
    "accruedmilestoneexpensecurrent": 7702000,
    "interestpayablecurrent": 4956000,
    "accruedcollaborationcostsharing": 2019000,
    "otheraccruedliabilitiescurrent": 5314000,
    "debtinstrumentfaceamount": 419400000,
    "conversionofsharesexcludedfromcomputationofdilutedeps": 5712253,
    "deferredfinancecostsnet": 3059000,
    "interestexpensedebt": 53200000,
    "amortizationoffinancingcosts": 7500000,
    "longtermdebt": 1544292000,
    "debtinstrumentfairvalue": 765046000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 419371000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 1150000000,
    "commonstockcapitalsharesreservedforfutureissuance": 200000,
    "commonstockincreaseincapitalsharesreservedforfutureissuanceinperiodshares": 7000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 48.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 38500,
    "employeebenefitsandsharebasedcompensation": 3100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": "550,110 options relating to the Unvested Tranche met the conditions for vesting in that the average closing price of the Company's common stock exceeded $105.74 during 20 consecutive trading days in August 2022 and the compound annual growth rate of the Company's common stock exceeded that of the Nasdaq Biotech Index by greater than 5%",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 550110,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 70.27,
    "compoundannualgrowthrate": 0.05,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 84.7,
    "allocatedsharebasedcompensationexpense": 109900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardplanmodificationincrementalcompensationcost": 123300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1044826,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1829632,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "2024-02-29",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 206600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.016,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y1M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.524,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.729,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9130140,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1777370,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 525893,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4692578,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 8696519,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 70.04,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 70.25,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 109.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 69.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 557927000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 289473000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 540503000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y",
    "aggregategrantdatefairvalueofsharesvested": 140889000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 12150000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 389761,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 145639,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 90.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 85.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 103.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 93.36,
    "saleofstockconsiderationreceivedontransaction": 7500000,
    "definedcontributionplancostrecognized": 6500000,
    "interestexpense": 53248000,
    "investmentincomeinterest": 16488000,
    "amortizationofdiscountspremiumsinvestmentscashequivalentandshortterminvestment": 11235000,
    "otherexpenseincome": -6921000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -251384000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -438579000,
    "currentstateandlocaltaxexpensebenefit": 13193000,
    "currentforeigntaxexpensebenefit": 944000,
    "currentincometaxexpensebenefit": 14137000,
    "deferredforeignincometaxexpensebenefit": -612000,
    "deferredincometaxexpensebenefit": -612000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.041,
    "effectiveincometaxratereconciliationresearchanddevelopmentandothertaxcredit": 0.069,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.147,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.033,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.012,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.132,
    "effectiveincometaxratereconciliationotheradjustments": 0.016,
    "effectiveincometaxratecontinuingoperations": -0.02,
    "valuationallowancedeferredtaxassetchangeinamount": 139600000,
    "operatinglosscarryforwards": 925700000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 229800000,
    "operatinglosscarryforwardsexpirationyear": 2023,
    "deferredtaxassetsoperatinglosscarryforwards": 241826000,
    "taxcreditcarryforwarddescription": "These federal and state research and development credits begin to expire between 2023 and 2042 and between 2023 and 2037, respectively.",
    "taxcreditcarryforwardamount": 180100000,
    "deferredtaxassetsdepreciationandamortization": 39725000,
    "deferredtaxassetsinprocessresearchanddevelopment": 261067000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 80193000,
    "deferredtaxassetsleaseliabilities": 11782000,
    "deferredtaxassetsinventory": 33366000,
    "deferredtaxassetsdebtdiscount": 35975000,
    "capitalizedresearchanddevelopmentcosts": 74886000,
    "deferredtaxassetsother": 44022000,
    "deferredtaxassetsgross": 822842000,
    "deferredtaxliabilitiesrightofuseasset": 9174000,
    "deferredincometaxliabilities": 9174000,
    "deferredtaxassetsvaluationallowance": 811908000,
    "deferredtaxassetsliabilitiesnet": 1760000,
    "unrecognizedtaxbenefits": 61704000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 8079000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 190000,
    "lesseeoperatingleasetermofcontract": "P15Y",
    "paymentsforrent": 38900000,
    "operatingleasecost": 18184000,
    "variableleasecost": 35505000,
    "leasecost": 53689000,
    "operatingleasepayments": 20778000,
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y4M24D",
    "operatingleaseweightedaveragediscountratepercent": 0.083,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 21046000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 20754000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 15324000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 8423000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 8518000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 27633000,
    "lesseeoperatingleaseliabilitypaymentsdue": 101698000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 28631000,
    "operatingleaseliabilitycurrent": 15489000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 11200000,
    "agreementexpirationdate": "2026-12-31",
    "agreementextensionterm": "The Company has the option to extend the term of the Aldevron Agreements by one year if the Company delivers a written notice of its intention to extend to Aldevron no later than June 1, 2025. Both parties have the right to early terminate without additional penalty. The Company has determined that the Aldevron Agreements do not contain an embedded lease because it does not convey the right to control the use of Aldevron’s facility or related equipment therein.",
    "cancellablefuturecommitments": 480800000,
    "researchanddevelopmentarrangementcontracttoperformforotherscostsincurredgross": 78700000,
    "contractualobligationdueinnexttwelvemonths": 649644000,
    "contractualobligationdueinsecondyear": 221774000,
    "contractualobligationdueinthirdyear": 162698000,
    "contractualobligationdueinfourthyear": 117220000,
    "contractualobligationdueinfifthyear": 117220000,
    "contractualobligationdueafterfifthyear": 117220000,
    "contractualobligation": 1385776000
  },
  {
    "date": "2021-12-30",
    "symbol": "SRPT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "SRPT",
    "entityregistrantname": "Sarepta Therapeutics, Inc.",
    "entitycentralindexkey": 873303,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "001-14895",
    "entitytaxidentificationnumber": "93-0797222",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "215 First Street",
    "entityaddressaddressline2": "Suite 415",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 617,
    "localphonenumber": "274-4000",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.0001 par value",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "KPMG LLP",
    "auditorlocation": "Boston, Massachusetts",
    "auditorfirmid": 185,
    "cashandcashequivalentsatcarryingvalue": 2115869000,
    "accountsreceivablenetcurrent": 152990000,
    "inventorynet": 186212000,
    "otherassetscurrent": 149028000,
    "assetscurrent": 2604099000,
    "propertyplantandequipmentnet": 191156000,
    "finitelivedintangibleassetsnet": 14239000,
    "operatingleaserightofuseasset": 45531000,
    "otherassetsnoncurrent": 292949000,
    "assets": 3147974000,
    "accountspayablecurrent": 76741000,
    "accruedliabilitiescurrent": 271697000,
    "contractwithcustomerliabilitycurrent": 89244000,
    "otherliabilitiescurrent": 15051000,
    "liabilitiescurrent": 452733000,
    "longtermloanspayable": 1096876000,
    "operatingleaseliabilitynoncurrent": 41512000,
    "contractwithcustomerliabilitynoncurrent": 574244000,
    "businesscombinationcontingentconsiderationliability": 43600000,
    "otherliabilitiesnoncurrent": 11000000,
    "liabilities": 2219965000,
    "commonstockvalue": 9000,
    "additionalpaidincapitalcommonstock": 4134768000,
    "accumulatedothercomprehensiveincomelossnetoftax": 20000,
    "retainedearningsaccumulateddeficit": -3206748000,
    "stockholdersequity": 928009000,
    "liabilitiesandstockholdersequity": 3147974000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 3333333,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 198000000,
    "commonstocksharesissued": 87126974,
    "commonstocksharesoutstanding": 87126974,
    "revenuefromcontractwithcustomerexcludingassessedtax": 612401000,
    "typeofrevenueextensiblelist": "http://fasb.org/us-gaap/2021-01-31#ProductMember",
    "revenuefromcollaborativearrangementexcludingrevenuefromcontractwithcustomer": 89486000,
    "revenues": 701887000,
    "costofgoodssoldexcludingamortization": 97049000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 771182000,
    "sellinggeneralandadministrativeexpense": 282660000,
    "settlementandlicensecharges": 10000000,
    "amortizationofintangibleassets": 706000,
    "costsandexpenses": 1161597000,
    "operatingincomeloss": -459710000,
    "gainlossondispositionofintangibleassets": 102000000,
    "gainlossoncontingentconsiderationsnet": 7200000,
    "othernonoperatingexpense": 68438000,
    "nonoperatingincomeexpense": 40762000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -418948000,
    "incometaxexpensebenefit": -168000,
    "netincomeloss": -418780000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -23000,
    "othercomprehensiveincomelossnetoftax": -23000,
    "comprehensiveincomenetoftax": -418803000,
    "earningspersharebasicanddiluted": -5.15,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 81262000,
    "sharesoutstanding": 87127000,
    "stockissuedduringperiodvaluestockoptionsexercised": 12963000,
    "stockissuedduringperiodsharesstockoptionsexercised": 283000,
    "restrictedstockunitsvested": 277000,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 1432000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": 18000,
    "issuanceofcommonstockforcashnetofofferingcosts": 1000,
    "issuanceofcommonstockforcashnetofofferingcostsshares": 7099000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 7839000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 112000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrestrictedstockunitsrequisiteserviceperiodrecognition": 113943000,
    "othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletononcontrollinginterest": 23000,
    "profitloss": -418780000,
    "depreciationdepletionandamortization": 38017000,
    "reductioninthecarryingamountsoftherightofuseassets": 11325000,
    "noncashinterestexpense": 7581000,
    "sharebasedcompensation": 113943000,
    "equitymethodinvestmentotherthantemporaryimpairment": 4488000,
    "othernoncashincomeexpense": -7620000,
    "increasedecreaseinaccountsreceivable": 51650000,
    "increasedecreaseininventories": 83772000,
    "increasedecreaseinotheroperatingassets": -103203000,
    "increasedecreaseindeferredrevenue": -89244000,
    "increasedecreaseinaccountspayableandaccruedexpensesandotherliabilities": 23297000,
    "netcashprovidedbyusedinoperatingactivities": -443172000,
    "paymentstoacquirepropertyplantandequipment": 38490000,
    "proceedsfromsaleofintangibleassets": 102000000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 29988000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 466000000,
    "otherinvestingactivity": 4109000,
    "netcashprovidedbyusedininvestingactivities": 495413000,
    "proceedsfromsalesofcommonstocknetofofferingcosts": 548532000,
    "proceedsfromstockoptionsexercised": 20802000,
    "taxespaidrelatedtonetsharesettlementofequityawards": 7765000,
    "netcashprovidedbyusedinfinancingactivities": 561569000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 613810000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 2125523000,
    "restrictedcashnoncurrent": 9654000,
    "restrictedcashnoncurrentassetstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 2125523000,
    "interestpaidnet": 55949000,
    "incometaxespaidnet": 583000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 13225000,
    "leaseliabilitiesterminated": 40133000,
    "noncashorpartnoncashacquisitionfixedassetsacquired1": 4162000,
    "cashcashequivalentsandshortterminvestments": 2125800000,
    "restrictedcashandinvestmentsnoncurrent": 9900000,
    "accountsreceivablepaymentterm": "P60D",
    "concentrationriskpercentage1": 0.48,
    "finitelivedintangibleassetusefullife": "P20Y",
    "commonstockclosingpricepercentage": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.15,
    "operatingleaseliability": 56600000,
    "increasedecreaseinconvertiblenotes": 96800000,
    "increasedecreaseinaccumulateddeficit": 60200000,
    "increasedecreaseinadditionalpaidincapital": 157000000,
    "earningspersharediluted": 0.28,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "Lesser of the useful life or the term of   the respective lease",
    "paymentforoptionexercise": 187000000,
    "preferredstockpurchasevalue": 1800000,
    "contractwithcustomerliability": 663500000,
    "deferredrevenuecurrent": 89200000,
    "deferredrevenueseparatematerialoptionsright": 485000000,
    "researchanddevelopmentexpense": 90500000,
    "collaborationreceivable": 18600000,
    "upfrontlicensefee": 2500000,
    "sublicensepayment": 28700000,
    "royaltyexpense": 31400000,
    "intangibleassetsnetexcludinggoodwill": 1200000,
    "developmentmilestoneandsettlementupfrontfeerecognizedasresearchanddevelopmentexpense": 50300000,
    "milestonepaymenttobepaidbycompanyuponspecifiedresearchmilestoneachievement": 11000000,
    "obligationsduetodevelopmentregulatorycommercialmilestoneandupfrontroyaltypayments": 4000000000,
    "proceedsfromsaleofrarepediatricdiseasepriorityreviewvouchernetofcommission": 102000000,
    "assetsfairvaluedisclosure": 1562358000,
    "liabilitiesfairvaluedisclosure": 43600000,
    "strategicequityinvestmentmemberaddition": 1800000,
    "assetsfairvalueadjustment": -4488000,
    "liabilitiesfairvalueadjustment": -7200000,
    "cashequivalentsatcarryingvalue": 1562358000,
    "cashandcashequivalentsamortizedcostbasis": 2115869000,
    "cashcashequivalentsandinvestmentsamortizedcostbasis": 2115869000,
    "cashcashequivalentsandinvestments": 2115869000,
    "billedcontractreceivables": 152990000,
    "allowancefordoubtfulaccountsreceivablecurrent": 799000,
    "provisionforreservesfordiscountsandallowances": 13308000,
    "paymentscreditsreservesfordiscountsandallowances": -14790000,
    "reservesforreductiontoaccountsreceivable": 8321000,
    "reservesforcomponentofaccruedexpenses": 62145000,
    "inventoryrawmaterialsnetofreserves": 58822000,
    "inventoryworkinprocessandrawmaterialsnetofreserves": 230194000,
    "inventoryfinishedgoodsnetofreserves": 26717000,
    "inventorycurrentandnoncurrentnet": 315733000,
    "inventorynoncurrent": 129521000,
    "manufacturingrelateddepositsandprepaidexpensecurrent": 93656000,
    "collaborationreceivablecurrent": 18647000,
    "prepaidclinicalandpreclinicalexpensescurrent": 12667000,
    "prepaidmaintenanceservicescurrent": 8452000,
    "prepaidresearchexpensescurrent": 3082000,
    "prepaidtaxes": 1100000,
    "prepaidinsurance": 5282000,
    "otherassetsmiscellaneouscurrent": 6142000,
    "otherinventorynoncurrent": 129521000,
    "manufacturingrelateddepositsandprepaidexpensenoncurrent": 112765000,
    "strategicinvestmentsnoncurrent": 34892000,
    "prepaidexpensenoncurrent": 2007000,
    "otherassetsmiscellaneousnoncurrent": 3860000,
    "propertyplantandequipmentgross": 103370000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 112632000,
    "depreciation": 36600000,
    "finitelivedintangibleassetsgross": 12382000,
    "finitelivedintangibleassetsaccumulatedamortization": 7015000,
    "inlincensedrights": 1000000,
    "expensesincurredoncapitalizedpatentstobeabandoned": 500000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1395000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1394000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1391000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1330000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1200000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 7529000,
    "finitelivedintangibleassetsamortizationexpenseonethroughfiveyears": 14239000,
    "employeerelatedliabilitiescurrent": 48299000,
    "accruedproductrevenuerelatedreservecurrent": 62145000,
    "accruedcontractmanufacturingexpensecurrent": 104311000,
    "accruedclinicalandpreclinicalcostscurrent": 25955000,
    "accruedprofessionalfeescurrent": 9381000,
    "accruedmilestoneexpensecurrent": 100000,
    "accruedroyaltiescurrent": 11965000,
    "accruedcollaborationcostsharing": 2887000,
    "interestpayablecurrent": 1045000,
    "otheraccruedliabilitiescurrent": 5609000,
    "debtinstrumentfaceamount": 569993000,
    "debtinstrumentfrequencyofperiodicpayment": "The 2024 Notes contain customary covenants and events of default, occurrence of which permits the certain holders to accelerate all outstanding obligations, including principal and interest.",
    "debtinstrumentinterestrateeffectivepercentage": 0.019,
    "proceedsfromdebtnetofissuancecosts": 244900000,
    "debtinstrumentunamortizeddiscount": 9400000,
    "deferredfinancecostsnet": 700000,
    "interestexpensedebt": 10700000,
    "increasedecreaseininterestexpense": 22400000,
    "longtermdebt": 563673000,
    "debtinstrumentfairvalue": 846138000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 250000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 869993000,
    "commonstockcapitalsharesreservedforfutureissuance": 400000,
    "commonstockincreaseincapitalsharesreservedforfutureissuanceinperiodshares": 7000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P24M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 13.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 3300000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 86.41,
    "allocatedsharebasedcompensationexpense": 50526000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 987464,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1320206,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "2023-08-31",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 175700000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.013,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P4Y11M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.601,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.708,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8196921,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1685860,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1050264,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2532438,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 7867722,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 69.39,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 45.71,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 112.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 84.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 68.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 248479000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 59069000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 247434000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y3M18D",
    "aggregategrantdatefairvalueofstockoptionsvested": 79068000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 10622000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 48875,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 337357,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 98.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 85.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 50.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 106.37,
    "saleofstockconsiderationreceivedontransaction": 7800000,
    "definedcontributionplancostrecognized": 5300000,
    "interestexpense": 63525000,
    "investmentincomeinterest": 354000,
    "amortizationofdiscountspremiumsinvestmentscashequivalentandshortterminvestment": 157000,
    "othernonoperatingincomeexpense": -936000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -47633000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -371315000,
    "currentstateandlocaltaxexpensebenefit": -40000,
    "currentforeigntaxexpensebenefit": 181000,
    "currentincometaxexpensebenefit": 141000,
    "deferredforeignincometaxexpensebenefit": -309000,
    "deferredincometaxexpensebenefit": -309000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.004,
    "effectiveincometaxratereconciliationresearchanddevelopmentandothertaxcredit": 0.1,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.098,
    "effectiveincometaxratereconciliationpermanentdifferences": -0.003,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.03,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.184,
    "effectiveincometaxratereconciliationotheradjustments": 0.001,
    "valuationallowancedeferredtaxassetchangeinamount": 66500000,
    "operatinglosscarryforwards": 1280400000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 577200000,
    "operatinglosscarryforwardsexpirationyear": 2022,
    "deferredtaxassetsoperatinglosscarryforwards": 330392000,
    "taxcreditcarryforwarddescription": "These federal and state research and development credits begin to expire between 2022 and 2041 and between 2022 and 2036, respectively.",
    "taxcreditcarryforwardamount": 139200000,
    "deferredtaxassetsdepreciationandamortization": 31563000,
    "deferredtaxassetsinprocessresearchanddevelopment": 201512000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 38132000,
    "deferredtaxassetsleaseliabilities": 10890000,
    "deferredtaxassetsinventory": 24172000,
    "deferredtaxassetsdebtdiscount": 5875000,
    "deferredtaxassetsother": 38315000,
    "deferredtaxassetsgross": 680851000,
    "deferredtaxliabilitiesrightofuseasset": 7405000,
    "deferredincometaxliabilities": 7405000,
    "deferredtaxassetsvaluationallowance": 672319000,
    "deferredtaxassetsliabilitiesnet": 1127000,
    "unrecognizedtaxbenefits": 53815000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 5503000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 163000,
    "operatingleasecost": 28737000,
    "variableleasecost": 18742000,
    "leasecost": 47479000,
    "operatingleasepayments": 24449000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y6M",
    "operatingleaseweightedaveragediscountratepercent": 0.076,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 18702000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 18326000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 17582000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 9052000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 571000,
    "lesseeoperatingleaseliabilitypaymentsdue": 64233000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 7672000,
    "operatingleaseliabilitycurrent": 15049000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent",
    "weightedaveragenumberofsharesoutstandingbasic": 81262000,
    "weightedaveragenumberofdilutedsharesoutstanding": 81262000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9700000,
    "conversionofsharesexcludedfromcomputationofdilutedeps": 7763552,
    "agreementexpirationdate": "2026-12-31",
    "agreementextensionterm": "The Company has the option to extend the term of the Aldevron Agreements by one year if the Company delivers a written notice of its intention to extend to Aldevron no later than June 1, 2025. Both parties have the right to early terminate without additional penalty. The Company has determined that the Aldevron Agreements do not contain an embedded lease because it does not convey the right to control the use of Aldevron’s facility or related equipment therein.",
    "cancellablefuturecommitments": 378500000,
    "researchanddevelopmentarrangementcontracttoperformforotherscostsincurredgross": 47900000,
    "contractualobligationdueinnexttwelvemonths": 647124000,
    "contractualobligationdueinsecondyear": 178345000,
    "contractualobligationdueinthirdyear": 138725000,
    "contractualobligationdueinfourthyear": 100838000,
    "contractualobligationdueinfifthyear": 54720000,
    "contractualobligationdueafterfifthyear": 109440000,
    "contractualobligation": 1229192000
  },
  {
    "date": "2020-12-30",
    "symbol": "SRPT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "SRPT",
    "entityregistrantname": "Sarepta Therapeutics, Inc.",
    "entitycentralindexkey": 873303,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "001-14895",
    "entitytaxidentificationnumber": "93-0797222",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "215 First Street",
    "entityaddressaddressline2": "Suite 415",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 617,
    "localphonenumber": "274-4000",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.0001 par value",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 1502648000,
    "shortterminvestments": 435923000,
    "accountsreceivablenetcurrent": 101340000,
    "inventorynet": 231961000,
    "otherassetscurrent": 213324000,
    "assetscurrent": 2485196000,
    "propertyplantandequipmentnet": 190430000,
    "finitelivedintangibleassetsnet": 13628000,
    "operatingleaserightofuseasset": 91761000,
    "otherassetsnoncurrent": 203703000,
    "assets": 2984718000,
    "accountspayablecurrent": 111090000,
    "accruedliabilitiescurrent": 193553000,
    "contractwithcustomerliabilitycurrent": 89244000,
    "otherliabilitiescurrent": 22139000,
    "liabilitiescurrent": 416026000,
    "longtermloanspayable": 992493000,
    "operatingleaseliabilitynoncurrent": 80367000,
    "contractwithcustomerliabilitynoncurrent": 663488000,
    "businesscombinationcontingentconsiderationliability": 50800000,
    "otherliabilitiesnoncurrent": 19785000,
    "liabilities": 2222959000,
    "commonstockvalue": 8000,
    "additionalpaidincapitalcommonstock": 3609877000,
    "accumulatedothercomprehensiveincomelossnetoftax": 3000,
    "retainedearningsaccumulateddeficit": -2848129000,
    "stockholdersequity": 761759000,
    "liabilitiesandstockholdersequity": 2984718000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 3333333,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 198000000,
    "commonstocksharesissued": 79374247,
    "commonstocksharesoutstanding": 79374247,
    "revenuefromcontractwithcustomerexcludingassessedtax": 455865000,
    "revenuefromcollaborativearrangementexcludingrevenuefromcontractwithcustomer": 84234000,
    "revenues": 540099000,
    "costofgoodssoldexcludingamortization": 63382000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 722343000,
    "sellinggeneralandadministrativeexpense": 317875000,
    "researchanddevelopmentinprocess": 173200000,
    "amortizationofintangibleassets": 662000,
    "costsandexpenses": 1104262000,
    "operatingincomeloss": -564163000,
    "gainlossondispositionofintangibleassets": 108069000,
    "losscontingencylossinperiod": 45000000,
    "othernonoperatingexpense": 51971000,
    "nonoperatingincomeexpense": 11098000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -553065000,
    "incometaxexpensebenefit": 1063000,
    "netincomeloss": -554128000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -47000,
    "othercomprehensiveincomelossnetoftax": -47000,
    "comprehensiveincomenetoftax": -554175000,
    "earningspersharebasicanddiluted": -7.11,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 77956000,
    "sharesoutstanding": 79374000,
    "stockissuedduringperiodvaluestockoptionsexercised": 76492000,
    "stockissuedduringperiodsharesstockoptionsexercised": 1443000,
    "restrictedstockunitsvested": 159000,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 6333000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": 37000,
    "issuanceofcommonstockforcashnetofofferingcosts": 312053000,
    "issuanceofcommonstockforcashnetofofferingcostsshares": 2522000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 7465000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 102000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrestrictedstockunitsrequisiteserviceperiodrecognition": 108070000,
    "othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletononcontrollinginterest": 47000,
    "profitloss": -554128000,
    "availableforsalesecuritiestransferstotradinggrossgains": 108069000,
    "depreciationdepletionandamortization": 26911000,
    "reductioninthecarryingamountsoftherightofuseassets": 12828000,
    "accretionamortizationofdiscountsandpremiumsshortterminvestments": 2186000,
    "noncashinterestexpense": 25454000,
    "sharebasedcompensation": 108070000,
    "othernoncashincomeexpense": 470000,
    "increasedecreaseinaccountsreceivable": 10461000,
    "increasedecreaseininventories": 60582000,
    "increasedecreaseinotheroperatingassets": 166328000,
    "increasedecreaseindeferredrevenue": 749429000,
    "increasedecreaseinaccountspayableandaccruedexpensesandotherliabilities": 41998000,
    "netcashprovidedbyusedinoperatingactivities": 107466000,
    "paymentstoacquirepropertyplantandequipment": 82202000,
    "proceedsfromsaleofintangibleassets": 108069000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 1333568000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 1189480000,
    "otherinvestingactivity": 3500000,
    "netcashprovidedbyusedininvestingactivities": -121721000,
    "proceedsfromissuanceofcommonstock": 312053000,
    "proceedsfromstockoptionsexercised": 83957000,
    "taxespaidrelatedtonetsharesettlementofequityawards": 4798000,
    "proceedsfromissuanceoflongtermdebt": 291150000,
    "paymentsofdebtissuancecosts": 39000,
    "netcashprovidedbyusedinfinancingactivities": 682323000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 668068000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 1511713000,
    "restrictedcashnoncurrent": 9065000,
    "restrictedcashnoncurrentassetstatementoffinancialpositionextensiblelist": "us-gaap:OtherAssetsNoncurrent",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 1511713000,
    "interestpaidnet": 34418000,
    "incometaxespaidnet": 2510000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 59327000,
    "noncashorpartnoncashacquisitionfixedassetsacquired1": 5151000,
    "shareswithheldfortaxincludedinaccruedexpenses": 6333000,
    "accrueddebtdiscountandissuancecosts": 11000000,
    "cashcashequivalentsandshortterminvestments": 1947800000,
    "restrictedcashandinvestmentsnoncurrent": 9300000,
    "numberofoperatingsegments": 1,
    "accountsreceivablepaymentterm": "P60D",
    "concentrationriskpercentage1": 0.47,
    "finitelivedintangibleassetusefullife": "P20Y",
    "commonstockclosingpricepercentage": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.15,
    "operatingleaseliability": 101300000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "Lesser of the useful life or the term of   the respective lease",
    "paymentforoptionexercise": 485000000,
    "directtransactionfees": 4300000,
    "contractwithcustomerliability": 752700000,
    "deferredrevenuecurrent": 89200000,
    "deferredrevenueseparatematerialoptionsright": 485000000,
    "researchanddevelopmentexpense": 66500000,
    "collaborationreceivable": 34200000,
    "businessacquisitiontotalconsideration": 178300000,
    "businessacquisitioncostofacquiredentitytransactioncosts": 8800000,
    "businesscombinationcontingentconsiderationliabilityincreased": 49500000,
    "upfrontlicensefee": 3700000,
    "regulatorymilestonepayable": 10000000,
    "finitelivedlicenseagreementsgross": 1000000,
    "royaltyexpense": 23200000,
    "intangibleassetsnetexcludinggoodwill": 900000,
    "developmentmilestoneandsettlementupfrontfeerecognizedasresearchanddevelopmentexpense": 17700000,
    "milestonepaymenttobepaidbycompanyuponspecifiedresearchmilestoneachievement": 14000000,
    "potentialoptionpaymentsuponexerciseofoptions": 237000000,
    "obligationsduetodevelopmentregulatorycommercialmilestoneandupfrontroyaltypayments": 3900000,
    "proceedsfromsaleofrarepediatricdiseasepriorityreviewvouchernetofcommission": 108100000,
    "assetsfairvaluedisclosure": 629440000,
    "liabilitiesfairvaluedisclosure": 50800000,
    "businesscombinationcontingentconsiderationarrangementschangeinamountofcontingentconsiderationliability1": 600000,
    "liabilitiesfairvalueadjustment": 45000000,
    "cashequivalentsatcarryingvalue": 629440000,
    "weightedaveragematurityperiodofavailableforsalesecurities": "P2M",
    "availableforsaledebtsecuritiesamortizedcostbasis": 1037959000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 22000,
    "availableforsalesecuritiesdebtsecurities": 1037981000,
    "cashandcashequivalentsamortizedcostbasis": 900590000,
    "cashandcashequivalentsgrossunrealizedgainbeforetax": 9000,
    "cashcashequivalentsandinvestmentsamortizedcostbasis": 1938549000,
    "cashcashequivalentsandinvestmentsgrossunrealizedgainbeforetax": 22000,
    "cashcashequivalentsandinvestments": 1938571000,
    "availableforsaledebtsecuritiescurrentamortizedcostbasis": 435910000,
    "availableforsaledebtsecuritiescurrentaccumulatedgrossunrealizedgainbeforetax": 13000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 435923000,
    "billedcontractreceivables": 100870000,
    "governmentcontractreceivable": 470000,
    "allowancefordoubtfulaccountsreceivablecurrent": 2281000,
    "provisionforreservesfordiscountsandallowances": 9700000,
    "paymentscreditsreservesfordiscountsandallowances": 8007000,
    "reservesforreductiontoaccountsreceivable": 8352000,
    "reservesforcomponentofaccruedexpenses": 42618000,
    "inventoryrawmaterialsnetofreserves": 71717000,
    "inventoryworkinprocessandrawmaterialsnetofreserves": 139704000,
    "inventoryfinishedgoodsnetofreserves": 20540000,
    "manufacturingrelateddepositsandprepaidexpensecurrent": 134430000,
    "collaborationreceivablecurrent": 34184000,
    "prepaidclinicalandpreclinicalexpensescurrent": 16224000,
    "prepaidmaintenanceservicescurrent": 6411000,
    "prepaidresearchexpensescurrent": 5854000,
    "prepaidtaxes": 4939000,
    "prepaidinsurance": 4158000,
    "leaseholdimprovementreceivablecurrent": 3059000,
    "otherassetsmiscellaneouscurrent": 4065000,
    "manufacturingrelateddepositsandprepaidexpensenoncurrent": 148525000,
    "strategicinvestmentsnoncurrent": 38799000,
    "prepaidexpensenoncurrent": 3395000,
    "otherassetsmiscellaneousnoncurrent": 3669000,
    "propertyplantandequipmentgross": 55019000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 76027000,
    "depreciation": 25200000,
    "finitelivedintangibleassetsgross": 11210000,
    "finitelivedintangibleassetsaccumulatedamortization": 7209000,
    "inlincensedrights": 1000000,
    "expensesincurredoncapitalizedpatentstobeabandoned": 100000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1527000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1277000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1277000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1270000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1213000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 7064000,
    "finitelivedintangibleassetsamortizationexpenseonethroughfiveyears": 13628000,
    "employeerelatedliabilitiescurrent": 50803000,
    "accruedproductrevenuerelatedreservecurrent": 42618000,
    "accruedcontractmanufacturingexpensecurrent": 36543000,
    "accruedclinicalandpreclinicalcostscurrent": 22169000,
    "accruedprofessionalfeescurrent": 10221000,
    "accruedmilestoneexpensecurrent": 9380000,
    "accruedroyaltiescurrent": 7793000,
    "accruedpropertyandequipmentcurrent": 4993000,
    "accruedcollaborationcostsharing": 3516000,
    "interestpayablecurrent": 1045000,
    "otheraccruedliabilitiescurrent": 4472000,
    "debtinstrumentfaceamount": 569993000,
    "debtinstrumentfrequencyofperiodicpayment": "The 2024 Notes contain customary covenants and events of default, occurrence of which permits the certain holders to accelerate all outstanding obligations, including principal and interest.",
    "debtinstrumentconvertibleconversionprice1": 73.42,
    "debtinstrumentinterestrateeffectivepercentage": 0.069,
    "proceedsfromdebtnetofissuancecosts": 244900000,
    "debtinstrumentunamortizeddiscount": 9400000,
    "deferredfinancecostsnet": 700000,
    "interestexpensedebt": 59900000,
    "longtermdebt": 464762000,
    "debtinstrumentfairvalue": 1394249000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 250000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 869993000,
    "commonstockcapitalsharesreservedforfutureissuance": 500000,
    "commonstockincreaseincapitalsharesreservedforfutureissuanceinperiodshares": 7000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 61.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 3300000,
    "cliffvestingperiod": "P5Y",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 122.25,
    "allocatedsharebasedcompensationexpense": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 623552,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 48875,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "2021-08-31",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 189800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.013,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.573,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.682,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7844947,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1402409,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 458756,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2020322,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 7500726,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 70.61,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 53.21,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 108.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 70.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 68.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 783558000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 202709000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 766936000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y10M24D",
    "aggregategrantdatefairvalueofstockoptionsvested": 80355000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 144750000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 83750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 3500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 50.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 120.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 34.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 142.71,
    "saleofstockconsiderationreceivedontransaction": 7500000,
    "definedcontributionplancostrecognized": 5300000,
    "definedcontributionplanminimumagelimitforeligibilitytoparticipateinplan": "P21Y",
    "interestexpense": 59947000,
    "investmentincomeinterest": 2970000,
    "amortizationofdiscountspremiumsinvestmentscashequivalentandshortterminvestment": 4489000,
    "othernonoperatingincomeexpense": 517000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -204956000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -348109000,
    "currentfederaltaxexpensebenefit": 4000,
    "currentstateandlocaltaxexpensebenefit": 624000,
    "currentforeigntaxexpensebenefit": 680000,
    "currentincometaxexpensebenefit": 1308000,
    "deferredforeignincometaxexpensebenefit": -245000,
    "deferredincometaxexpensebenefit": -245000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.04,
    "effectiveincometaxratereconciliationresearchanddevelopmentandothertaxcredit": 0.066,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.213,
    "effectiveincometaxratereconciliationpermanentdifferences": 0.022,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.129,
    "effectiveincometaxratereconciliationotheradjustments": 0.002,
    "effectiveincometaxratecontinuingoperations": -0.002,
    "valuationallowancedeferredtaxassetchangeinamount": 117000000,
    "operatinglosscarryforwardsvaluationallowance": 7900000,
    "operatinglosscarryforwards": 1298300000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 581300000,
    "deferredtaxassetsoperatinglosscarryforwards": 333703000,
    "taxcreditcarryforwardamount": 111900000,
    "deferredtaxassetsdepreciationandamortization": 31259000,
    "deferredtaxassetsinprocessresearchanddevelopment": 159917000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 31212000,
    "deferredtaxassetsleaseliabilities": 13120000,
    "deferredtaxassetsinventory": 35959000,
    "deferredtaxassetsother": 28381000,
    "deferredtaxassetsgross": 633551000,
    "deferredtaxliabilitiesrightofuseasset": 8772000,
    "deferredtaxliabilitiesdebtdiscount": 18044000,
    "deferredincometaxliabilities": 26816000,
    "deferredtaxassetsvaluationallowance": 605848000,
    "deferredtaxassetsliabilitiesnet": 887000,
    "unrecognizedtaxbenefits": 48475000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 6722000,
    "numberofdedicatedcleanroomsuite": 4,
    "cleanroomsuitereservationfeespayments": 52700000,
    "operatingleasecost": 18978000,
    "variableleasecost": 17065000,
    "leasecost": 36043000,
    "operatingleasepayments": 19344000,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y7M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.076,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 27846000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 25513000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 25615000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 25430000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 10910000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 4131000,
    "lesseeoperatingleaseliabilitypaymentsdue": 119445000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 18148000,
    "operatingleaseliabilitycurrent": 20930000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "us-gaap:OtherLiabilitiesCurrent",
    "weightedaveragenumberofsharesoutstandingbasic": 77956000,
    "weightedaveragenumberofdilutedsharesoutstanding": 77956000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9000000,
    "agreementexpirationdate": "2026-12-31",
    "agreementextensionterm": "The Company has the option to extend the term of the Aldevron Agreements by one year if the Company delivers a written notice of its intention to extend to Aldevron no later than June 1, 2025. Both parties have the right to early terminate without additional penalty. The Company has determined that the Aldevron Agreements do not contain an embedded lease because it does not convey the right to control the use of Aldevron’s facility or related equipment therein.",
    "prepayments": 16300000,
    "percentageofprepaymentscreditedbackequaltobatchinvoiceamount": 0.5,
    "cancellablefuturecommitments": 280900000,
    "researchanddevelopmentarrangementcontracttoperformforotherscostsincurredgross": 40400000,
    "contractualobligationdueinnexttwelvemonths": 632257000,
    "contractualobligationdueinsecondyear": 208485000,
    "contractualobligationdueinthirdyear": 107612000,
    "contractualobligationdueinfourthyear": 105932000,
    "contractualobligationdueinfifthyear": 101932000,
    "contractualobligationdueafterfifthyear": 138217000,
    "contractualobligation": 1294435000
  },
  {
    "date": "2019-12-30",
    "symbol": "SRPT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "SRPT",
    "entityregistrantname": "Sarepta Therapeutics, Inc.",
    "entitycentralindexkey": 873303,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-14895",
    "entitytaxidentificationnumber": "93-0797222",
    "entityincorporationstatecountrycode": "DE",
    "entityaddressaddressline1": "215 First Street",
    "entityaddressaddressline2": "Suite 415",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2142,
    "cityareacode": 617,
    "localphonenumber": "274-4000",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, $0.0001 par value",
    "securityexchangename": "NASDAQ",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 835080000,
    "shortterminvestments": 289668000,
    "accountsreceivablenetcurrent": 90879000,
    "inventorynet": 171379000,
    "otherassetscurrent": 81907000,
    "assetscurrent": 1468913000,
    "propertyplantandequipmentnet": 129620000,
    "finitelivedintangibleassetsnet": 12497000,
    "operatingleaserightofuseasset": 37933000,
    "otherassetsnoncurrent": 173859000,
    "assets": 1822822000,
    "accountspayablecurrent": 68094000,
    "accruedliabilitiescurrent": 185527000,
    "otherliabilitiescurrent": 11146000,
    "liabilitiescurrent": 264767000,
    "longtermloanspayable": 681900000,
    "operatingleaseliabilitynoncurrent": 47720000,
    "otherliabilitiesnoncurrent": 10248000,
    "liabilities": 1004635000,
    "commonstockvalue": 8000,
    "additionalpaidincapitalcommonstock": 3112130000,
    "accumulatedothercomprehensiveincomelossnetoftax": 50000,
    "retainedearningsaccumulateddeficit": -2294001000,
    "stockholdersequity": 818187000,
    "liabilitiesandstockholdersequity": 1822822000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 3333333,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 99000000,
    "commonstocksharesissued": 75184863,
    "commonstocksharesoutstanding": 75184863,
    "revenuefromcontractwithcustomerexcludingassessedtax": 380833000,
    "typeofrevenueextensiblelist": "us-gaap:ProductMember",
    "revenues": 380833000,
    "costofgoodssoldexcludingamortization": 56586000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 560909000,
    "sellinggeneralandadministrativeexpense": 284812000,
    "researchanddevelopmentinprocess": 173240000,
    "settlementandlicensecharges": 10000000,
    "amortizationofintangibleassets": 849000,
    "costsandexpenses": 1086396000,
    "operatingincomeloss": -705563000,
    "othernonoperatingexpense": 8317000,
    "nonoperatingincomeexpense": -8317000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -713880000,
    "incometaxexpensebenefit": 1195000,
    "netincomeloss": -715075000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 149000,
    "othercomprehensiveincomelossnetoftax": 149000,
    "comprehensiveincomenetoftax": -714926000,
    "earningspersharebasicanddiluted": -9.71,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 73615000,
    "sharesoutstanding": 75185000,
    "stockissuedduringperiodsharesstockoptionsexercised": 1055715,
    "stockissuedduringperiodvaluestockoptionsandstockappreciationrightsexercised": 31522000,
    "stockissuedduringperiodsharesstockoptionsandappreciationsrightsexercised": 1125000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 68000,
    "adjustmentsrelatedtotaxwithholdingforsharebasedcompensation": 9135000,
    "sharespaidfortaxwithholdingforsharebasedcompensation": 78000,
    "issuanceofcommonstockforcashnetofofferingcosts": 1000,
    "issuanceofcommonstockforcashnetofofferingcostsshares": 2604000,
    "stockissuedduringperiodvalueforcollaborationagreement": 29415000,
    "stockissuedduringperiodshareforcollaborationagreement": 302000,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 5079000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 92000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrestrictedstockunitsrequisiteserviceperiodrecognition": 78602000,
    "othercomprehensiveincomeavailableforsalesecuritiesadjustmentnetoftaxportionattributabletononcontrollinginterest": -149000,
    "profitloss": -715075000,
    "noncashupfrontpayment": 29415000,
    "depreciationdepletionandamortization": 30547000,
    "accretionamortizationofdiscountsandpremiumsshortterminvestments": 8445000,
    "noncashinterestexpense": 21444000,
    "sharebasedcompensation": 78602000,
    "othernoncashexpense": 690000,
    "increasedecreaseinaccountsreceivable": 41835000,
    "increasedecreaseininventories": 45934000,
    "increasedecreaseinotheroperatingassets": 102091000,
    "increasedecreaseinaccountspayableandaccruedliabilitiesleaseliabilitiesandotherliabilities": 122979000,
    "netcashprovidedbyusedinoperatingactivities": -456463000,
    "paymentstoacquirepropertyplantandequipment": 59631000,
    "paymentstoacquireintangibleassets": 3082000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 1193632000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 1715626000,
    "paymentstoacquirebusinessesnetofcashacquired": 172556000,
    "netcashprovidedbyusedininvestingactivities": 286725000,
    "proceedsfromstockoptionsexercised": 36601000,
    "taxespaidrelatedtonetsharesettlementofequityawards": 4337000,
    "proceedsfromissuanceofcommonstock": 365354000,
    "proceedsfromissuanceoflongtermdebt": 245625000,
    "paymentsofdebtissuancecosts": 689000,
    "netcashprovidedbyusedinfinancingactivities": 642554000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 472816000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 843645000,
    "restrictedcashnoncurrent": 8565000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 843645000,
    "interestpaidnet": 8550000,
    "incometaxespaidnet": 933000,
    "shareswithheldfortaxincludedinaccruedexpenses": 4798000,
    "accrueddebtdiscountandissuancecosts": 5000000,
    "noncashorpartnoncashacquisitionfixedassetsacquired1": 1181000,
    "cashcashequivalentsandshortterminvestments": 1134400000,
    "restrictedcashandinvestmentsnoncurrent": 9600000,
    "numberofoperatingsegments": 1,
    "accountsreceivablepaymentterm": "P60D",
    "concentrationriskpercentage1": 0.43,
    "finitelivedintangibleassetusefullife": "P20Y",
    "commonstockclosingpricepercentage": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawarddiscountfrommarketpricepurchasedate": 0.15,
    "operatingleaseliability": 60100000,
    "researchanddevelopmentexpense": 9000000,
    "businessacquisitioncostofacquiredentitytransactioncosts": 165000000,
    "additionaldevelopmentmilestonepaymentstobepaid": 200000000,
    "businesscombinationcontingentconsiderationliability": 4500000,
    "regulatorymilestonepayable": 10000000,
    "finitelivedlicenseagreementsgross": 1000000,
    "royaltyexpense": 19400000,
    "intangibleassetsnetexcludinggoodwill": 1100000,
    "obligationsduetodevelopmentregulatorycommercialmilestoneandupfrontroyaltypayments": 3000000000,
    "developmentmilestoneandsettlementupfrontfeerecognizedasresearchanddevelopmentexpense": 113200000,
    "businesscombinationacquisitionrelatedcosts": 8753000,
    "businessacquisitiontotalconsideration": 178253000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcashandequivalents": 1197000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentassetsprepaidexpenseandotherassets": 3816000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedassets": 178253000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcontingentliability": 4500000,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedliabilities": 4500000,
    "assetsfairvaluedisclosure": 203410000,
    "liabilitiesfairvaluedisclosure": 5200000,
    "cashequivalentsatcarryingvalue": 203410000,
    "weightedaveragematurityperiodofavailableforsalesecurities": "P2M",
    "availableforsaledebtsecuritiesamortizedcostbasis": 809090000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 71000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 2000,
    "availableforsalesecuritiesdebtsecurities": 809159000,
    "cashandcashequivalentsamortizedcostbasis": 315589000,
    "cashandcashequivalentsgrossunrealizedgainbeforetax": 36000,
    "cashcashequivalentsandinvestmentsamortizedcostbasis": 1124679000,
    "cashcashequivalentsandinvestmentsgrossunrealizedgainbeforetax": 71000,
    "cashcashequivalentsandinvestmentsgrossunrealizedlossbeforetax": 2000,
    "cashcashequivalentsandinvestments": 1124748000,
    "availableforsaledebtsecuritiescurrentamortizedcostbasis": 289635000,
    "availableforsaledebtsecuritiescurrentaccumulatedgrossunrealizedgainbeforetax": 35000,
    "availableforsaledebtsecuritiescurrentaccumulatedgrossunrealizedlossbeforetax": 2000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 289668000,
    "billedcontractreceivables": 90409000,
    "governmentcontractreceivable": 470000,
    "allowancefordoubtfulaccountsreceivablecurrent": 588000,
    "provisionforreservesfordiscountsandallowances": 9698000,
    "paymentscreditsreservesfordiscountsandallowances": 10488000,
    "reservesforreductiontoaccountsreceivable": 6254000,
    "reservesforcomponentofaccruedexpenses": 45249000,
    "inventoryrawmaterialsnetofreserves": 82030000,
    "inventoryworkinprocessandrawmaterialsnetofreserves": 88031000,
    "inventoryfinishedgoodsnetofreserves": 1318000,
    "manufacturingrelateddepositsandprepaidexpensecurrent": 54276000,
    "prepaidclinicalandpreclinicalexpensescurrent": 8263000,
    "prepaidmaintenanceservicescurrent": 4366000,
    "leaseholdimprovementreceivablecurrent": 3059000,
    "prepaidinsurance": 2573000,
    "prepaidtaxes": 2114000,
    "prepaidresearchexpensescurrent": 2007000,
    "otherassetsmiscellaneouscurrent": 5249000,
    "manufacturingrelateddepositsandprepaidexpensenoncurrent": 122091000,
    "strategicinvestmentsnoncurrent": 31937000,
    "prepaidexpensenoncurrent": 4665000,
    "deferredtaxassetstaxcreditcarryforwardsalternativeminimumtax": 3367000,
    "otherassetsmiscellaneousnoncurrent": 2233000,
    "propertyplantandequipmentgross": 53950000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 50995000,
    "depreciation": 22800000,
    "finitelivedintangibleassetsgross": 8902000,
    "finitelivedintangibleassetsaccumulatedamortization": 5507000,
    "inlincensedrights": 1000000,
    "expensesincurredoncapitalizedpatentstobeabandoned": 200000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 1358000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 1168000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 1156000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 1156000,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 1149000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 6510000,
    "finitelivedintangibleassetsamortizationexpenseonethroughfiveyears": 12497000,
    "accruedproductrevenuerelatedreservecurrent": 45249000,
    "employeerelatedliabilitiescurrent": 43240000,
    "accruedcontractmanufacturingexpensecurrent": 27622000,
    "accruedmilestoneexpensecurrent": 18390000,
    "accruedclinicalandpreclinicalcostscurrent": 18010000,
    "accruedprofessionalfeescurrent": 10707000,
    "accruedcollaborationcostsharing": 9000000,
    "accruedroyaltiescurrent": 6301000,
    "otheraccruedliabilitiescurrent": 7008000,
    "debtinstrumentfaceamount": 570000000,
    "debtinstrumentfrequencyofperiodicpayment": "The 2024 Notes were issued at face value and bear interest at the rate of 1.50% per annum, payable semi-annually in cash on each May 15 and November 15, commencing on May 15, 2018.",
    "debtinstrumentconvertibleconversionprice1": 73.42,
    "debtinstrumentinterestrateeffectivepercentage": 0.069,
    "lineofcreditfacilityprepaymentfeepercentage": 0.02,
    "lineofcreditfacilitycommitmentfeepercentage": 0.0175,
    "debtinstrumentunamortizeddiscount": 9400000,
    "deferredfinancecostsnet": 700000,
    "proceedsfromdebtnetofissuancecosts": 244900000,
    "interestexpensedebt": 30700000,
    "longtermdebt": 441896000,
    "debtinstrumentfairvalue": 1141288000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 250000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 570000000,
    "commonstockcapitalsharesreservedforfutureissuance": 600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 70.93,
    "allocatedsharebasedcompensationexpense": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 511283,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdate": "2020-02-29",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 131.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 136125,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 181100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.014,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.025,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.525,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.689,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 8346348,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1429652,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 418760,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2368621,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 7987427,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 61.01,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 132.97,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 30.73,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 84.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 45.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 58.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 587191000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 199438000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 578938000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y4M24D",
    "aggregategrantdatefairvalueofstockoptionsvested": 50878000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 109707000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 100840,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 15356,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 42.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 40.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 48.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsexercised": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentotherthanoptionsoutstandingweightedaverageexercisedprice": 23.85,
    "saleofstockconsiderationreceivedontransaction": 5100000,
    "definedcontributionplancostrecognized": 3400000,
    "definedcontributionplanminimumagelimitforeligibilitytoparticipateinplan": "P21Y",
    "interestexpense": 30669000,
    "investmentincomeinterest": 7238000,
    "amortizationofdiscountspremiumsinvestmentscashequivalentandshortterminvestment": 15350000,
    "othernonoperatingincomeexpense": -236000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -489747000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -224133000,
    "currentstateandlocaltaxexpensebenefit": 521000,
    "currentforeigntaxexpensebenefit": 1050000,
    "currentincometaxexpensebenefit": 1571000,
    "deferredfederalincometaxexpensebenefit": -15000,
    "deferredstateandlocalincometaxexpensebenefit": -5000,
    "deferredforeignincometaxexpensebenefit": -356000,
    "deferredincometaxexpensebenefit": -376000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.063,
    "effectiveincometaxratereconciliationresearchanddevelopmentandothertaxcredit": 0.033,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.168,
    "effectiveincometaxratereconciliationpermanentdifferences": 0.018,
    "effectiveincometaxratereconciliationbasisdifferenceinsubsidiary": -0.084,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.074,
    "effectiveincometaxratecontinuingoperations": -0.002,
    "valuationallowancedeferredtaxassetchangeinamount": 119500000,
    "operatinglosscarryforwardsvaluationallowance": 7900000,
    "operatinglosscarryforwards": 1166200000,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 579900000,
    "operatinglosscarryforwardsexpirationyear": 2020,
    "deferredtaxassetsoperatinglosscarryforwards": 304033000,
    "taxcreditcarryforwarddescription": "These federal and state research and development credits begin to expire between 2020 and 2039 and between 2020 and 2034, respectively.",
    "taxcreditcarryforwardamount": 74700000,
    "taxcreditcarryforwardexpirationyear": 2020,
    "deferredtaxassetsdepreciationandamortization": 40095000,
    "deferredtaxassetsinprocessresearchanddevelopment": 103806000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 24114000,
    "deferredtaxassetsleaseliabilities": 15796000,
    "deferredtaxassetsdeferredrevenue": 939000,
    "deferredtaxassetsinventory": 18255000,
    "deferredtaxassetsother": 16270000,
    "deferredtaxassetsgross": 523308000,
    "deferredtaxliabilitiesrightofuseasset": 10782000,
    "deferredtaxliabilitiesdebtdiscount": 23099000,
    "deferredincometaxliabilities": 33881000,
    "deferredtaxassetsvaluationallowance": 488829000,
    "deferredtaxassetsliabilitiesnet": 598000,
    "unrecognizedtaxbenefits": 41753000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 4275000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 109000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 175000,
    "deferredrentcreditnoncurrent": -18000000,
    "operatingleasecost": 10335000,
    "variableleasecost": 3967000,
    "leasecost": 14302000,
    "operatingleasepayments": 10416000,
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y6M",
    "operatingleaseweightedaveragediscountratepercent": 0.075,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 11718000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 12891000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 11080000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 11230000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 11471000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 9654000,
    "lesseeoperatingleaseliabilitypaymentsdue": 68044000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 12478000,
    "operatingleaseliabilitycurrent": 7846000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "us-gaap:OtherLiabilitiesCurrent",
    "weightedaveragenumberofsharesoutstandingbasic": 73615000,
    "weightedaveragenumberofdilutedsharesoutstanding": 73615000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9100000,
    "advanceupfrontfeetobepaidonexecutionofagreements": 20000000,
    "cashpaymentunderagreements": 75500000,
    "agreementexpirationdate": "2019-12-31",
    "purchaseobligation": 4000000,
    "usagefeesperannumpercleanroomsuite": 1000000,
    "cleanroomsuitereservationfees": 48000000,
    "percentageofcreditoncleanroomusefeeifthresholdmet": 1,
    "cleanroomsuitereservationfeespayments": 40100000,
    "agreementextensionterm": "The Company exercised the option to extend the CCSA to December 31, 2020 (the “2020 Option”) and has another option to extend the term of the CCSA for an additional year to December 31, 2021 (the “2021 Renewal Right”).",
    "percentageofprepaymentscreditedbackequaltobatchinvoiceamount": 0.5,
    "prepayments": 22800000,
    "cancellablefuturecommitments": 91400000,
    "researchanddevelopmentarrangementcontracttoperformforotherscostsincurredgross": 31600000,
    "contractualobligationdueinnexttwelvemonths": 378744000,
    "contractualobligationdueinsecondyear": 183661000,
    "contractualobligationdueinthirdyear": 64653000,
    "contractualobligationdueinfourthyear": 58319000,
    "contractualobligationdueinfifthyear": 58309000,
    "contractualobligationdueafterfifthyear": 149350000,
    "contractualobligation": 893036000
  }
]